Early antibiotic use is associated with CMV risk and outcomes following allogeneic hematopoietic cell transplantation. Read more about Early antibiotic use is associated with CMV risk and outcomes following allogeneic hematopoietic cell transplantation.
Reduced immunogenicity of the adjuvanted recombinant zoster vaccine after hematopoietic cell transplant: a pilot study. Read more about Reduced immunogenicity of the adjuvanted recombinant zoster vaccine after hematopoietic cell transplant: a pilot study.
Clinical value of measurable residual disease testing for assessing depth, duration, and direction of response in multiple myeloma. Read more about Clinical value of measurable residual disease testing for assessing depth, duration, and direction of response in multiple myeloma.
Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report. Read more about Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report.
CRISPR-based screens uncover determinants of immunotherapy response in multiple myeloma. Read more about CRISPR-based screens uncover determinants of immunotherapy response in multiple myeloma.
Diagnostic assay to assist clinical decisions for unclassified severe combined immune deficiency. Read more about Diagnostic assay to assist clinical decisions for unclassified severe combined immune deficiency.
Geriatric assessment in older alloHCT recipients: association of functional and cognitive impairment with outcomes. Read more about Geriatric assessment in older alloHCT recipients: association of functional and cognitive impairment with outcomes.
Coinherited genetics of multiple myeloma and its precursor, monoclonal gammopathy of undetermined significance. Read more about Coinherited genetics of multiple myeloma and its precursor, monoclonal gammopathy of undetermined significance.
Prolonged lenalidomide maintenance therapy improves the depth of response in multiple myeloma. Read more about Prolonged lenalidomide maintenance therapy improves the depth of response in multiple myeloma.
Myelodysplastic syndrome unrelated to lentiviral vector in a patient treated with gene therapy for sickle cell disease. Read more about Myelodysplastic syndrome unrelated to lentiviral vector in a patient treated with gene therapy for sickle cell disease.
